Sino Biological, a biotech company listed on the Shenzhen stock exchange subsidiary (ChiNext), which provides mammalian cell-based recombinant proteins and related CRO services, opened its new Center for Bioprocessing (C4B) in Houston, TX, at Levit Green, next to the Texas Medical Center.

“With the establishment of our new Center for Bioprocessing here in Houston, we are excited to mark a significant milestone in Sino Biological’s global presence,” said Yingmin, Zhu, PhD, head of the new C4B.

“The C4B represents Sino Biological’s natural global expansion of its contract research services capabilities and extends upon the company’s CRO service offering at its Beijing headquarters,” added Rob Burgess, PhD, CBO for Sino Biological. “The focus of this new center will be on the development and production of research- and diagnostic-grade proteins and antibodies utilizing mammalian cells, which possess the unique machinery to yield natural, in vivo-like products with high bioactivity.”

Previous articleSet to Join the NGS Race, Ultima Genomics Offers a Peek under the Hood
Next articleWhy Recombinants Are Essential for Assay Development and Production